Alerts will be sent to your verified email
Verify EmailARYAVAN
Ecofinity Atomix
|
Novelix Pharma
|
Scarnose Internatl.
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-0.02 % | -17.5 % | 18.34 % |
5yr average Equity Multiplier
|
3.13 | 1.26 | 61.29 |
5yr Average Asset Turnover Ratio
|
0.6 | 0.84 | 3.99 |
5yr Avg Net Profit Margin
|
-27.47 % | -14.11 % | 0.29 % |
Price to Book
|
0.93 | 3.89 | 0.0 |
P/E
|
18.11 | 334.94 | 146.03 |
5yr Avg Cash Conversion Cycle
|
106.94 Days | 29.1 Days | 167.36 Days |
Inventory Days
|
11.61 Days | 34.04 Days | 0.15 Days |
Days Receivable
|
117.32 Days | 55.38 Days | 207.67 Days |
Days Payable
|
258.61 Days | 55.7 Days | 71.95 Days |
5yr Average Interest Coverage Ratio
|
144.8 | -17.77 | 11.74 |
5yr Avg ROCE
|
1.51 % | -15.4 % | 25.09 % |
5yr Avg Operating Profit Margin
|
-43.96 % | -16.49 % | -0.11 % |
5 yr average Debt to Equity
|
0.49 | 0.05 | 0.18 |
5yr CAGR Net Profit
|
n/a | 35.78 % | -19.73 % |
5yr Average Return on Assets
|
-0.74 % | -13.36 % | 1.65 % |
Shareholdings
|
|||
Promoter Holding
|
0.82 % | 66.56 % | 0.0 |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-63.72 % | -0.36 % | -61.9 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Ecofinity Atomix
|
Novelix Pharma
|
Scarnose Internatl.
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|